Close Menu
Home › About Us › Our Staff › Turna Ray

Turna Ray

Managing Editor, Precision Oncology News
Phone Number
+1-212-651-5626
Email
[email protected]
Turna Ray at Genomeweb / 360dx Turna Ray at Genomeweb / 360dx

Turna Ray has been covering the personalized medicine and molecular diagnostics industries for GenomeWeb since 2006. She closely tracks the evolving regulatory, reimbursement, and business environment for precision medicine products. 

Articles Authored by Turna Ray

Feb 06, 2020

Despite Barriers, Labs Starting to Report Suspected Cancer Risk Mutations Seen in Tumor Testing

Premium

Paired tumor/germline analysis is not routinely done in cancer care, but some labs are starting to report incidental germline findings alongside patient's tumor profiles.

Jan 27, 2020

Colon Cancer Biomarker Undertesting Rates in Real-World Data Points to Precision Oncology Barriers

Premium

The findings should spur cancer centers to review testing rates and address barriers, said experts from Hackensack University, Cota Healthcare, and Guardant Health. 

Jan 21, 2020

Genetic Testing Challenges in Oncology: Patient Told Genetic Test was Negative Turns out to be MAP Carrier

Jan 13, 2020

Taproot's Master Observational Trial Attempting to Gather Missing Outcomes Data in Precision Oncology

Premium

With the participation of five cancer centers and clinics, Taproot is hoping to build a national, prospective data registry that is much needed but has been difficult to advance to date.

Dec 12, 2019

ACMG Suggests Docs Evaluate All Breast Cancer Patients for Genetic Risk Test Suitability

Absent sufficient evidence to support genetic testing for all patients, the group recommended following existing guidelines, which are based on clinical factors.

Dec 12, 2019

Universal Genetic Testing in Breast Cancer May Result in More Harm Than Good, Experts Worry

Premium

Amid rapid adoption of multi-gene panels, ACMG experts are seeing some doctors and patients taking actions they shouldn't.

Dec 09, 2019

Beat AML Umbrella Trial Demonstrates Feasibility of Rapid Precision Medicine Approach

Premium

The study, presented at the American Society of Hematology meeting, also suggested that a moleculary guided strategy may lead to better outcomes than standard of care.

Dec 09, 2019

ASH Study: Germline Testing Identifies Cancer Risk Mutations, VUS in Older AML Patients

An analysis found a 14 percent prevalence of germline cancer risk mutations and a 57 percent prevalence of variants of unknown significance.

Dec 02, 2019

Genetic Testing Challenges in Oncology: False Positive After Testing at Pop-Up Booth

A case series in partnership with My Gene Counsel to highlight the challenges genetics professionals and oncologists are grappling with as genetic testing is increasingly used in patient care. 

Nov 12, 2019

Bristol-Myers, PathAI Show Artificial Intelligence Is on Par With Manual PD-L1 Scoring

Premium

The results are of interest to drugmakers looking for scalable technology solutions for assessment of PD-L1 for predicting immunotherapy response.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.